FDL169
FDL169 is a pharmaceutical drug with 7 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A DDI Study of FDL169 and FDL176 in Healthy Subjects
An Phase 1 Study to Evaluate the Pharmacokinetic (PK) Profile of FDL169 New Formulations in Healthy Subjects
A Study to Compare the Pharmacokinetics of Different Oral Formulations of FDL169 in Healthy Subjects
A Study to Evaluate Safety, PK and PD of FDL169 in Cystic Fibrosis Subjects
Bioavailability and Pharmacokinetics Study of FDL169 in Healthy Subjects and Subjects With Cystic Fibrosis
Clinical Trials (7)
A DDI Study of FDL169 and FDL176 in Healthy Subjects
An Phase 1 Study to Evaluate the Pharmacokinetic (PK) Profile of FDL169 New Formulations in Healthy Subjects
A Study to Compare the Pharmacokinetics of Different Oral Formulations of FDL169 in Healthy Subjects
A Study to Evaluate Safety, PK and PD of FDL169 in Cystic Fibrosis Subjects
Bioavailability and Pharmacokinetics Study of FDL169 in Healthy Subjects and Subjects With Cystic Fibrosis
FTIH - Single and Repeat Oral Doses of FDL169 in Healthy Volunteers
Pharmacokinetics of FDL169 in Healthy Female Subjects
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7